CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Pathfinder Cell Therapy Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Pathfinder Cell Therapy Inc
12 Bow St
Phone: (617) 245-0289p:617 245-0289 CAMBRIDGE, MA  02138  United States Ticker: PFNDPFND

This company ceased filing statements with the SEC on 3/30/2016.

Business Summary
Pathfinder Cell Therapy, Inc. is a regenerative medicine company. The Company is seeking to develop cell-based and related therapies for the treatment of a range of diseases and medical conditions characterized by organ-specific cell damage. The Company is engaged in developing cell-based therapy for the treatment of diabetes, renal disease, myocardial infarction and other diseases characterized by organ-specific cell damage. The Company has discovered a mammalian cell type, which is able to stimulate damaged tissues to regenerate without the Pathfinder Cells (PCs) themselves being incorporated into the new tissue. PCs have shown efficacy in approximately three different animal models of diabetes, cardiac ischemia and renal reperfusion injury. The Company has tested these models for PCs from both rat and human sources. As of September 30, 2015, the Company had no revenue generated.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
9/30/201512/31/2014YesYes---

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Chairman of the Board JoergGruber 54 9/1/2011 4/1/2007
President, Chief Executive Officer, Secretary, Director Richard L.Franklin 69 9/2/2011 12/1/2000
Chief Financial Officer, Treasurer John M.Benson 53 9/2/2011 9/2/2011
4 additional Officers and Directors records available in full report.

Business Names
Business Name
Pathfinder, LLC
PFND
SyntheMed Inc.

General Information
Number of Employees: 1 (As of 12/31/2012)
Outstanding Shares: 667,160,870 (As of 9/30/2015)
Shareholders: 1,200
Stock Exchange: OTC
Federal Tax Id: 141745197


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Monday, August 28, 2023